Page last updated: 2024-09-04

ym 09151-2 and bemesetron

ym 09151-2 has been researched along with bemesetron in 1 studies

Compound Research Comparison

Studies
(ym 09151-2)
Trials
(ym 09151-2)
Recent Studies (post-2010)
(ym 09151-2)
Studies
(bemesetron)
Trials
(bemesetron)
Recent Studies (post-2010) (bemesetron)
249613254325

Protein Interaction Comparison

ProteinTaxonomyym 09151-2 (IC50)bemesetron (IC50)
5-hydroxytryptamine receptor 3EHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.097
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.0928
5-hydroxytryptamine receptor 3DHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3CHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altier, H; Jantos, H; Monti, D; Monti, JM; Ponzoni, A1

Other Studies

1 other study(ies) available for ym 09151-2 and bemesetron

ArticleYear
Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
    European journal of pharmacology, 1995, May-15, Volume: 278, Issue:2

    Topics: Animals; Benzamides; Benzazepines; Biguanides; Dopamine Antagonists; Injections; Male; Nucleus Accumbens; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Sleep; Sleep, REM; Tropanes; Wakefulness

1995